• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Fayed, A., Elmenshawy, A., Rashwan Aly, M. (2024). EVALUATION OF THE ROLE OF INTRAVENOUS METOPROLOL IN THE OUTCOME OF SEVERE TRAUMATIC BRAIN INJURY. ALEXMED ePosters, 6(3), 7-8. doi: 10.21608/alexpo.2024.302039.1879
Akram Muhammad Fayed; Ahmed Mostafa Elmenshawy; Marwan Mohamed Elsayed Rashwan Aly. "EVALUATION OF THE ROLE OF INTRAVENOUS METOPROLOL IN THE OUTCOME OF SEVERE TRAUMATIC BRAIN INJURY". ALEXMED ePosters, 6, 3, 2024, 7-8. doi: 10.21608/alexpo.2024.302039.1879
Fayed, A., Elmenshawy, A., Rashwan Aly, M. (2024). 'EVALUATION OF THE ROLE OF INTRAVENOUS METOPROLOL IN THE OUTCOME OF SEVERE TRAUMATIC BRAIN INJURY', ALEXMED ePosters, 6(3), pp. 7-8. doi: 10.21608/alexpo.2024.302039.1879
Fayed, A., Elmenshawy, A., Rashwan Aly, M. EVALUATION OF THE ROLE OF INTRAVENOUS METOPROLOL IN THE OUTCOME OF SEVERE TRAUMATIC BRAIN INJURY. ALEXMED ePosters, 2024; 6(3): 7-8. doi: 10.21608/alexpo.2024.302039.1879

EVALUATION OF THE ROLE OF INTRAVENOUS METOPROLOL IN THE OUTCOME OF SEVERE TRAUMATIC BRAIN INJURY

Article 1, Volume 6, Issue 3, July 2024, Page 7-8  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2024.302039.1879
View on SCiNiTO View on SCiNiTO
Authors
Akram Muhammad Fayed; Ahmed Mostafa Elmenshawy; Marwan Mohamed Elsayed Rashwan Aly email
Department of Critical Care Medicine, Faculty of Medicine, Alexandria University
Abstract
Traumatic brain injury (TBI) is a non-degenerative, non-congenital insult to the brain from an external mechanical force, possible lead to permanent or temporary impairment of cognitive, physical, and psychological functions, associated with diminished or altered state of consciousness. severe TBI presented by a headache, vomiting or nausea, convulsions, weakness or numbness in the limbs, loss of coordination, confusion.Signs of increased ICP which is Cushing's triad( wide pulse pressure, bradycardia, irregular respiration) indicates significantly raised ICP.
A hyper-adrenergic state found with severe TBIpresentsas a mild formas SIRS or up to the paroxysmal sympathetic storms (PSS), which is the most severe form of the hyper-adrenergic states (called “brain storms”).
Beta blockers have Neuroprotective effects through decreased cerebral blood flow and decreased glucose and oxygen consumption, thus reducing cerebral metabolism.but this potential benefit remains purely speculative and restricted only to B-blockers that can cross blood brain barriers.

AIM OF THE WORK:
The aim of this study was to compare the effect of intravenous metoprolol vs placebo in severe traumatic brain injury patients and how it affected patient heart rate control, mortality, hospital stay, mechanical ventilation (MV) days, ICU stay.
Keywords
Traumatic brain injury (TBI); INTRAVENOUS METOPROLOL; paroxysmal sympathetic storms (PSS)
Supplementary Files
download 20.pdf
Statistics
Article View: 60
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.